Overview

Investigating the Role of Diazepam on Brain Function and Chemistry in Psychosis Risk

Status:
Completed
Trial end date:
2023-03-24
Target enrollment:
Participant gender:
Summary
This study will investigate whether a single dose of diazepam (5mg) compared to placebo can modulate brain chemistry (GABA/glutamate levels) and function (blood flow, neural response and connectivity during tasks and at-rest) in 24 individuals at clinical high-risk for psychosis.
Phase:
N/A
Details
Lead Sponsor:
King's College London
Collaborators:
The Royal Society
Wellcome Trust
Treatments:
Ascorbic Acid
Diazepam